Clinical trial
S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small…
NCT00002969 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00002969 |
|---|---|
| Title | S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer |
| Official title | Phase II Trial of Paclitaxel by 96-Hour Infusion in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | paclitaxel |
| Enrollment | 60 |
| Start date | May 1, 1997 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2007 |
| First posted | Aug 24, 2004 |
| Last update posted | Jul 24, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: